Total Payments
$23,423
2024 Payments
$3,110
Companies
69
Transactions
1,445
Medicare Patients
7,855
Medicare Billing
$675,766
Payment Breakdown by Category
Food & Beverage$23,256 (99.3%)
Education$167.27 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,256 | 1,434 | 99.3% |
| Education | $167.27 | 11 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,367 | 87 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,885 | 180 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,653 | 112 | $0 (2024) |
| PFIZER INC. | $1,517 | 117 | $0 (2024) |
| Amgen Inc. | $1,504 | 88 | $0 (2024) |
| ABBVIE INC. | $1,317 | 104 | $0 (2024) |
| Novo Nordisk Inc | $1,084 | 65 | $0 (2024) |
| Lilly USA, LLC | $1,059 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $997.08 | 83 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $949.66 | 72 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,110 | 157 | AstraZeneca Pharmaceuticals LP ($869.52) |
| 2023 | $3,479 | 171 | AstraZeneca Pharmaceuticals LP ($825.63) |
| 2022 | $3,934 | 213 | AstraZeneca Pharmaceuticals LP ($844.51) |
| 2021 | $3,606 | 221 | GlaxoSmithKline, LLC. ($631.81) |
| 2020 | $2,797 | 190 | Amgen Inc. ($452.93) |
| 2019 | $2,772 | 214 | GlaxoSmithKline, LLC. ($392.86) |
| 2018 | $977.95 | 66 | GlaxoSmithKline, LLC. ($162.02) |
| 2017 | $2,747 | 213 | PFIZER INC. ($376.72) |
All Payment Transactions
1,445 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Neurology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Biological | ||||||
| 10/29/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,729 | 2,599 | $325,802 | $156,901 |
| 2022 | 30 | 1,865 | 3,954 | $339,141 | $156,111 |
| 2021 | 35 | 2,187 | 3,442 | $363,939 | $182,528 |
| 2020 | 35 | 2,074 | 3,369 | $380,949 | $180,225 |
Total Patients
7,855
Total Services
13,364
Medicare Billing
$675,766
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 368 | $63,150 | $28,705 | 45.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 352 | $49,560 | $21,146 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 140 | 140 | $21,125 | $16,898 | 80.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 291 | $39,690 | $15,498 | 39.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 49 | 50 | $15,750 | $14,106 | 89.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 38 | 41 | $14,170 | $8,073 | 57.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 83 | $14,905 | $7,563 | 50.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 92 | 93 | $12,240 | $7,039 | 57.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 68 | $12,290 | $6,710 | 54.6% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 23 | 185 | $20,650 | $4,539 | 22.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 64 | 73 | $10,632 | $4,479 | 42.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 136 | 140 | $4,200 | $4,059 | 96.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 29 | $7,960 | $3,851 | 48.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 135 | 135 | $3,375 | $2,272 | 67.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 71 | $7,100 | $2,250 | 31.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 51 | 52 | $4,065 | $1,600 | 39.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 28 | 29 | $3,400 | $1,600 | 47.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 15 | $2,460 | $1,221 | 49.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 46 | 47 | $1,175 | $1,152 | 98.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 23 | 81 | $4,860 | $1,075 | 22.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 22 | $2,200 | $771.20 | 35.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 36 | $3,240 | $769.54 | 23.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 18 | 35 | $1,050 | $432.25 | 41.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 43 | $1,550 | $371.35 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 32 | $1,915 | $316.76 | 16.5% |
About Dr. Gregory Allen, M.D
Dr. Gregory Allen, M.D is a Family Medicine healthcare provider based in Ponchatoula, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952398356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Allen, M.D has received a total of $23,423 in payments from pharmaceutical and medical device companies, with $3,110 received in 2024. These payments were reported across 1,445 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($23,256).
As a Medicare-enrolled provider, Allen has provided services to 7,855 Medicare beneficiaries, totaling 13,364 services with total Medicare billing of $675,766. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Ponchatoula, LA
- Active Since 09/30/2005
- Last Updated 11/07/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952398356
Products in Payments
- TRELEGY ELLIPTA (Drug) $2,008
- BREZTRI (Drug) $1,675
- FARXIGA (Drug) $1,084
- CYCLOSET (Drug) $941.01
- VRAYLAR (Drug) $903.08
- XIFAXAN (Drug) $774.27
- NURTEC ODT (Drug) $629.67
- Ozempic (Drug) $616.75
- ELIQUIS (Drug) $595.84
- Kerendia (Drug) $456.84
- APTIOM (Drug) $446.46
- EVENITY (Biological) $436.82
- JARDIANCE (Drug) $424.36
- TRADJENTA (Drug) $386.68
- MOUNJARO (Drug) $374.80
- CHANTIX (Drug) $357.59
- XARELTO (Drug) $345.10
- ANORO (Drug) $339.52
- Aimovig (Biological) $324.54
- Vascepa (Drug) $320.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.